US-based medical device company LKC Technologies has secured the Brazilian Health Regulatory Agency (Anvisa) approval for the RETeval device and associated Sensor Strips skin electrodes.

The RETeval device is a portable, handheld, functional diagnostic device for medical professionals to diagnose patients with diabetic retinopathy, glaucoma, CRVO, pediatric nystagmus and inherited diseases.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The device provides ‘highly reliable’ results without the need for dilation by using a patented, built-in pupillometry.

LKC’s patented disposable Sensor Strips are designed to offer ‘safe and accurate’ testing. They are comfortable for patients and easy to apply.

Furthermore, they are said to be specifically helpful in the pediatric market and where the use of corneal electrodes is not possible.

The company is collaborating with Centro MédicoLogístico (CML) to offer physicians broader access to RETeval device globally.

LKC Technologies president Jim Datovech said: “The Brazilian approval of the RETeval device and the Sensor Strip skin electrodes is a landmark moment for both LKC and the ocular health of the Brazilian population from big cities to the most remote of locations.

“Building on its history, LKC is driven to make functional diagnostics available to all clinicians, aiding in faster and more accurate diagnosis of complex eye diseases. We are grateful for the dedication of CML and the LKC team for their extraordinary commitment to make this approval a reality.”

LKC develops devices for the aid and management of ophthalmic disorders. The company was founded by Jerome Leight, Sigmund Krassowsky and Frank Chenin 1975.